| Autor: |
Alonso-Muñoz MC; Hospital de la Santa Creu i Sant Pau, Barcelona., Ojeda-González MB, Beltran-Fabregat M, Dorca-Ribugent J, López-López L, Borrás-Balada J, Cardenal-Alemany F, Gómez-Batiste X, Fabregat-Mayol J, Viladiu-Quemada P |
| Jazyk: |
angličtina |
| Zdroj: |
Oncology [Oncology] 1988; Vol. 45 (5), pp. 350-3. |
| DOI: |
10.1159/000226639 |
| Abstrakt: |
In a randomized trial, 105 postmenopausal women with advanced carcinoma of the breast received tamoxifen or aminoglutethimide or combined tamoxifen and aminoglutethimide. No differences were found in the rate of responses and duration of responses between the treatment groups. Toxicity was significantly greater (p less than 0.01) in patients who received aminoglutethimide. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
